31:56 Novel Therapeutics for Breast Cancer: CDK Inhibitors, Immunotherapy, and Role of TILs HMP Education
31:21 Novel Therapeutics for Breast Cancer: HER2+ and Triple Negative Disease; New Pathways, Targets HMP Education
38:22 Adjuvant/Neoadjuvant Therapy for Breast Cancer: Updates and Molecular Predictors of Benefit HMP Education
